UniTTEC(SZ:000925)2025-08-25 08:30Financial Performance - In the first half of 2025, the company achieved total revenue of approximately 688 million CNY, a year-on-year increase of 13.77% [2] - The net profit was -66.70 million CNY, with a year-on-year growth of 24.77% [2] - The non-recurring net profit was -74.21 million CNY, reflecting a year-on-year increase of 21.23% [2] - Despite remaining in a loss position, the company narrowed its loss compared to the same period last year while achieving revenue and net profit growth [2] Business Development - The company has made significant progress in the low-altitude economy, launching three core products: the tri-redundant flight control computer, smart take-off and landing field, and low-altitude integrated service platform [2] - Collaborations with major manufacturers in the UAV sector have led to signed orders and ongoing ground and flight testing [2] - The establishment of a joint venture with Hangzhou Low Altitude Company focuses on "full lifecycle services for low-altitude governance flights" [2] Shareholder and Stock Repurchase Information - Hangzhou Urban Investment holds 4.79% of the company's shares, making it the largest shareholder [3] - As of July 31, 2025, the company has repurchased 3,274,600 shares, accounting for 0.48% of the total share capital, with a total transaction amount of 24,620,654 CNY [3] Loss Reduction Factors - The reduction in losses is attributed to increased orders and project delivery scale in the smart transportation business, as well as steady growth in the semiconductor single crystal silicon materials sector [3] - Effective cost control measures have also contributed to the improvement in overall gross profit [3] Challenges and Future Strategies - The gross margin of the smart transportation business has declined due to varying project requirements and economic conditions across different regions [3] - The company plans to implement management reforms, process optimizations, and increased R&D investment to enhance product quality and market share [3] - Continuous orders exceeding 2.5 billion CNY in the rail transportation sector over the past three years indicate potential for steady future growth, although various factors may impact performance [3] Health Sector Developments - The health business encompasses three main areas: scientific anti-aging research, medical device CDMO, and synthetic biology health products [4] - Products in the health sector are primarily developed through outsourcing, with a focus on innovative solutions in anti-aging and health technology [4] Future Directions - The company aims for digital transformation as a primary development pathway, focusing on building an integrated transportation ecosystem and enhancing core industries [4] - The establishment of a new base in Pujiang is underway, with production expected to start this year [4] - Collaborative investments in computing power and infrastructure development are being pursued to support future growth [4]